These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19739423)
1. An employer perspective on annual employee and dependent costs for pediatric asthma. Kleinman NL; Brook RA; Ramachandran S Ann Allergy Asthma Immunol; 2009 Aug; 103(2):114-20. PubMed ID: 19739423 [TBL] [Abstract][Full Text] [Related]
2. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102 [TBL] [Abstract][Full Text] [Related]
3. Absenteeism and health-benefit costs among employees with MS. Brook RA; Rajagopalan K; Kleinman NL; Melkonian AK Curr Med Res Opin; 2009 Jun; 25(6):1469-76. PubMed ID: 19422277 [TBL] [Abstract][Full Text] [Related]
4. The economic burden of gout on an employed population. Brook RA; Kleinman NL; Patel PA; Melkonian AK; Brizee TJ; Smeeding JE; Joseph-Ridge N Curr Med Res Opin; 2006 Jul; 22(7):1381-9. PubMed ID: 16834837 [TBL] [Abstract][Full Text] [Related]
5. The economic consequences of irritable bowel syndrome: a US employer perspective. Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202 [TBL] [Abstract][Full Text] [Related]
6. Effect of antihypertensive medication adherence among employees with hypertension. Lynch WD; Markosyan K; Melkonian AK; Pesa J; Kleinman NL Am J Manag Care; 2009 Dec; 15(12):871-80. PubMed ID: 20001168 [TBL] [Abstract][Full Text] [Related]
7. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy. Luskin A; Bukstein D; Kocevar VS; Yin DD Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761 [TBL] [Abstract][Full Text] [Related]
8. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409 [TBL] [Abstract][Full Text] [Related]
9. The economic impact of bipolar disorder in an employed population from an employer perspective. Gardner HH; Kleinman NL; Brook RA; Rajagopalan K; Brizee TJ; Smeeding JE J Clin Psychiatry; 2006 Aug; 67(8):1209-18. PubMed ID: 16965198 [TBL] [Abstract][Full Text] [Related]
10. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Brook RA; Wahlqvist P; Kleinman NL; Wallander MA; Campbell SM; Smeeding JE Aliment Pharmacol Ther; 2007 Sep; 26(6):889-98. PubMed ID: 17767473 [TBL] [Abstract][Full Text] [Related]
11. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities. O'Connor RD; Parasuraman B; Roberts C; Leibman C Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758 [TBL] [Abstract][Full Text] [Related]
13. The association between employee obesity and employer costs: evidence from a panel of U.S. employers. Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722 [TBL] [Abstract][Full Text] [Related]
14. Economic burden of urge urinary incontinence in the workplace. Kleinman NL; Chen CI; Atkinson A; Odell K; Zou KH J Occup Environ Med; 2014 Mar; 56(3):266-9. PubMed ID: 24603202 [TBL] [Abstract][Full Text] [Related]
15. Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children. Van Dole KB; Swern AS; Newcomb K; Nelsen L Ann Allergy Asthma Immunol; 2009 Mar; 102(3):198-204. PubMed ID: 19354065 [TBL] [Abstract][Full Text] [Related]
16. Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder. Rajagopalan K; Kleinman NL; Brook RA; Gardner HH; Brizee TJ; Smeeding JE Curr Med Res Opin; 2006 Mar; 22(3):443-52. PubMed ID: 16574028 [TBL] [Abstract][Full Text] [Related]
17. Ratio of controller to total asthma medications: determinants of the measure. Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912 [TBL] [Abstract][Full Text] [Related]
18. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder. Centorrino F; Mark TL; Talamo A; Oh K; Chang J J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727 [TBL] [Abstract][Full Text] [Related]